Hivid®
Company
Roche Laboratories, Inc.
Use
Used in combination with antiretroviral agents for the treatment of HIV infection
Features
Third antiretroviral approved by FDA for HIV/AIDS
NIH Contribution
Didieoxycytidine (ddC) as inhibitor of HIV reverse-transcriptase
Approval Type
FDA
HHS Institute/Agency
NCI
Inventor(s)
H. Mitsuya
Year
1992
Tech Cat
Therapeutic
![L-026-1987 L-026-1987](/sites/default/files/styles/large/public/images/showcase/29172/hivid-60.jpg?itok=m_NbOu5e)